A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer-Reference-Cited by-同舟云学术

A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer

Published:2005-09 Issue:3 Volume:49 Page:395-400
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Stephens Richard J.,Girling David J.,Hopwood Penelope,Thatcher Nicholas

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference9 articles.

1. Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small cell lung cancer treated with radiation therapy;Curran;J Clin Oncol,1990

2. Bronchus;Woll,1994

3. Multimodality treatment of stage IIIA non-small cell lung carcinoma: a critical review of the literature and strategies for future research;Strauss;J Clin Oncol,1992

4. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Boston, Massachusetts: Medical Outcomes Trust.

5. World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication no. 48. Geneva: WHO.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of care in locally advanced carcinoma lung: An audit from radiation Oncologist’s perspective;2023-05-05

2. Adjuvante Mediastinalbestrahlung bei nichtkleinzelligem Lungenkarzinom (pN2);Die Onkologie;2022-11-03

3. Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial;ESMO Open;2022-04

4. Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials;ESMO Open;2022-04

5. Multimodality Treatment of Stage IIIA/N2 NSCLC: Why Always NO to Surgery?;Medical Radiology;2021